A Walking Intervention Among Men With Prostate Cancer: A Pilot Study

被引:21
|
作者
Pernar, Claire H. [1 ]
Fall, Katja [2 ]
Rider, Jennifer R. [3 ]
Markt, Sarah C. [1 ]
Adami, Hans-Olov [1 ,4 ]
Andersson, Sven-Olof [5 ]
Valdimarsdottir, Unnur [1 ,4 ,6 ]
Andren, Ove [5 ]
Mucci, Lorelei A. [1 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[2] Orebro Univ, Sch Hlth & Med Sci, Dept Clin Epidemiol & Biostat, Orebro, Sweden
[3] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[4] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[5] Orebro Univ, Sch Hlth & Med Sci, Dept Urol, Orebro, Sweden
[6] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland
基金
美国国家卫生研究院;
关键词
Biomarkers; Cardiovascular health; Exercise; Quality of life; Randomized trial; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; ANDROGEN SUPPRESSION THERAPY; PHYSICAL-ACTIVITY; RADICAL PROSTATECTOMY; AEROBIC EXERCISE; DEPRIVATION THERAPY; DIAGNOSIS; RESISTANCE; SURVIVORS;
D O I
10.1016/j.clgc.2017.05.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Men diagnosed with prostate cancer have increased risk of disease progression, cardiovascular events, and quality of life impairments. Men with a recent diagnosis randomly assigned to a walking group intervention maintained 10,000 steps per day and experienced improvement in cardiovascular biomarkers compared with usual care. A larger walking group intervention is needed to investigate its potential for improvement in longterm outcomes. Background: Men diagnosed with prostate cancer have increased risk for disease progression, cardiovascular events, and impairments in quality of life. This pilot study evaluated the feasibility of a randomized walking group intervention to improve quality of life, circulating biomarkers, and morbidity among men with newly diagnosed prostate cancer. Methods: Men were recruited at rebro University Hospital, Sweden, and randomized to an 11-week walking group intervention (n = 21) or usual care (n = 20). The intervention included weekly 1-hour walking group sessions and maintenance of 10,000 steps/day. Outcomes were changes in body composition, clinical factors, biomarkers of cardiovascular health, and quality of life between baseline and end of study. Analysis of covariance was used to compare outcomes in each group adjusted for baseline values. Results: All 41 men randomized completed the 11week trial. Men assigned to the intervention walked on average 10,644 steps/day, and 92% reported missing 2 or fewer sessions. Both groups experienced similar weight loss at 11 weeks. Men in the intervention had a significant adjusted mean change in high-density lipoprotein of 0.14 mmol/L (95% confidence interval [CI], 0.01-0.27; P =.04), and suggestive adjusted mean changes in low-density lipoprotein of = 0.22 mmol/L (95% CI, = 0.47 to 0.03; P =.08) and in systolic blood pressure of = 8.5 mm Hg (95% CI, = 21.2 to 4.2; P =.18), compared with the usual care group. Conclusions: A walking group intervention among men with recent diagnosis of prostate cancer is feasible and potentially effective in improving cardiovascular health. A larger randomized trial of longer duration is required to elucidate its potential for improvement in longer term outcomes. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:E1021 / E1028
页数:8
相关论文
共 50 条
  • [41] Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study
    Pedro C. Barata
    Prateek Mendiratta
    Brandie Heald
    Stefan Klek
    Petros Grivas
    Davendra P. S. Sohal
    Jorge A. Garcia
    Targeted Oncology, 2018, 13 : 495 - 500
  • [42] A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer
    Rundle, Andrew
    Neckerman, Kathryn M.
    Sheehan, Daniel
    Jankowski, Michelle
    Kryvenko, Oleksandr N.
    Tang, Deliang
    Rybicki, Benjamin A.
    CANCER CAUSES & CONTROL, 2013, 24 (02) : 297 - 303
  • [43] A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer
    Andrew Rundle
    Kathryn M. Neckerman
    Daniel Sheehan
    Michelle Jankowski
    Oleksandr N. Kryvenko
    Deliang Tang
    Benjamin A. Rybicki
    Cancer Causes & Control, 2013, 24 : 297 - 303
  • [45] FEASIBILITY AND ACCEPTABILITY OF WEB-BASED BEHAVIORAL INTERVENTION IN MEN WITH PROSTATE CANCER (PCA): A RANDOMIZED PILOT TRIAL
    Van Blarigan, Erin
    Kenfield, Stacey
    Ramsdill, Justin
    Daniel, Kimi
    Macaire, Greta
    Kessler, Elizabeth R.
    Beer, Tomasz M.
    Lyons, Karen S.
    Broering, Jeanette M.
    Carroll, Peter
    Winters-Stone, Kerri M.
    Chan, June
    ANNALS OF BEHAVIORAL MEDICINE, 2020, 54 : S47 - S47
  • [46] Bone mass and the risk of prostate cancer among men: The Framingham Study.
    Zhang, Y
    Kiel, D
    Ellison, C
    Schatskin, A
    Kreger, B
    Dorgan, J
    Cupples, A
    Felson, DT
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S159 - S159
  • [47] PSA and obesity among men with localized prostate cancer: results of the ANDROCAN study
    Meunier, Matthias E.
    Neuzillet, Yann
    Dreyfus, Jean-Francois
    Schneider, Marc
    Roupret, Morgan
    Cathelineau, Xavier
    Raynaud, Jean-Pierre
    Lebret, Thierry
    Botto, Henry
    WORLD JOURNAL OF UROLOGY, 2021, 39 (08) : 2945 - 2951
  • [48] HIV-Response Intergenerational Participation Intervention Among Black Men in Ontario, Canada: Protocol for a Pilot Intervention Study
    Etowa, Egbe B.
    Boakye, Priscilla N.
    Antabe, Roger
    Wong, Josephine Pui-Hing
    JMIR RESEARCH PROTOCOLS, 2023, 12
  • [49] PSA and obesity among men with localized prostate cancer: results of the ANDROCAN study
    Matthias E. Meunier
    Yann Neuzillet
    Jean-François Dreyfus
    Marc Schneider
    Morgan Rouprêt
    Xavier Cathelineau
    Jean-Pierre Raynaud
    Thierry Lebret
    Henry Botto
    World Journal of Urology, 2021, 39 : 2945 - 2951
  • [50] Psychiatric needs assessment in men with prostate cancer: A pilot program
    Roth, AJ
    Kornblith, AB
    BatelCopel, L
    Peabody, E
    Holland, JC
    Scher, HI
    PSYCHOSOMATICS, 1997, 38 (02) : 38 - 38